HY-18302-10mg
|
MedChemexpress LLC
|
c-Kit-IN-5-1 [CAS 1003311-62-3]
|
|
COVID-19-immunoregulation
|
|
HY-18302-25mg
|
MedChemexpress LLC
|
c-Kit-IN-5-1 [CAS 1003311-62-3]
|
|
COVID-19-immunoregulation
|
|
HY-18302-5mg
|
MedChemexpress LLC
|
c-Kit-IN-5-1 [CAS 1003311-62-3]
|
|
COVID-19-immunoregulation
|
|
HY-18302-1mL
|
MedChemexpress LLC
|
c-Kit-IN-5-1 [CAS 1003311-62-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-109086-10mg
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7]
|
|
COVID-19-immunoregulation
|
|
HY-109086-100mg
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7]
|
|
COVID-19-immunoregulation
|
|
HY-109086-25mg
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7]
|
|
COVID-19-immunoregulation
|
|
HY-109086-5mg
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7]
|
|
COVID-19-immunoregulation
|
|
HY-109086-50mg
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7]
|
|
COVID-19-immunoregulation
|
|
HY-109086-1mL
|
MedChemexpress LLC
|
Edicotinib [CAS 1142363-52-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10408-10mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-2mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-5mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-50mg
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1]
|
|
COVID-19-immunoregulation
|
|
HY-10408-1mL
|
MedChemexpress LLC
|
Ki20227 [CAS 623142-96-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|